	Empirical noise mapping guides optimal region-of-interest selection for accurate noise estimation in prostate DWI. J Appl Clin Med Phys Medved M, Chatterjee A, Yousuf A, Gundogdu B, Oto A, Karczmar GS. PMID: 42682154 [PubMed - indexed for MEDLINE]
	International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder. Am J Surg Pathol Downes MR, Wobker SE, Smith SC, Eckstein M, Akgul M, Baydar DE, Brimo F, Compérat E, Hartmann A, Kamat AM, Lobo A, Raspollini MR, Sangoi AR, Shariat SF, Tsuzuki T, van Rhijn BWG, Williamson SR, van Leenders GJLH, Cheng L, Lopez-Beltran A, Members of ISUP GU Cancer Treatment Effects Consensus Panel. PMID: 42682094 [PubMed - as supplied by publisher]
	Primary malignant melanoma of the female urethra: a case report and literature review. Can J Urol Xie J, Zhang Q, Wu J, Ma Y, Yan Y, Huang X. PMID: 42682069 [PubMed - indexed for MEDLINE]
	Renal Ewing sarcoma with an unusual presentation: a case report. Can J Urol Lübbersmeyer F, Lindfeld P, Fisch M, Dahlem R, Von Deimling M. PMID: 42682068 [PubMed - indexed for MEDLINE]
	At a glans: metastatic prostate cancer disguised as penile squamous cell carcinoma; a case report. Can J Urol Narasimhan R, Sugiyama K, Wang J, Munarriz R, Sarita-Reyes C. PMID: 42682067 [PubMed - indexed for MEDLINE]
	Unintended consequences of antibiotic practices: the relationship between bowel preparation, prolonged prophylaxis, and ileus after radical cystectomy. Can J Urol Manivasagam SS, Clark JY, Raman JD. PMID: 42682052 [PubMed - indexed for MEDLINE]
	Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer. Can J Urol Freitas CSM, Rocha-Silva F, Marques-Silva TA, de Oliveira ACR, da Silva SG, Santos Cardoso FD, Soares AN. PMID: 42682049 [PubMed - indexed for MEDLINE]
	Pathologic failure and salvage approaches following focal therapy for localized prostate cancer. Can J Urol Tremblay S, Tabei SS, Tayebi S, Hinrichs BH, Lazarovich A, Koehler J, Hsu WW, Verma S, Sidana A. PMID: 42682046 [PubMed - indexed for MEDLINE]
	Artificial intelligence advances in cystoscopy and imaging for bladder cancer: a narrative review. Can J Urol Khalid U, Shah N, Kavia R, Batura D. PMID: 42682041 [PubMed - indexed for MEDLINE]
	Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [(225)Ac]Ac-/[(177)Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study. BMC Cancer Amghar M, Hielscher T, Rausch T, Özgür H, Bauder-Wüst U, Rathke H, Bruchertseifer F, Morgenstern A, Roscher M, Bene, Kratochwil C, Bene. PMID: 42681619 [PubMed - indexed for MEDLINE]
	Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin. Cancer Med Odagiri K, Morikawa T, Naiki T, Sugiyama Y, Tasaki Y, Mimura Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Ishikawa D, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Furukawa-Hibi Y, Yasui T. PMID: 42681561 [PubMed - indexed for MEDLINE]
	Delphi consensus of specialist radiologists on imaging criteria for gadolinium contrast use and whole-body MRI in prostate cancer. Insights Imaging Onwuharine EN, Clark AJ, Dimmock M, Hill J. PMID: 42681263 [PubMed]
	Renal cell carcinoma: molecular understanding and therapeutic development. Cell Death Differ Hou T, Hua X, Ni W, Yan P, Inuzuka H, Wei W. PMID: 42680845 [PubMed - as supplied by publisher]
	Editorial for "Accuracy of Quantitative Chemical-Exchange-Saturation-Transfer Imaging for Grading Prostate Cancer and Predicting Adverse Pathology". J Magn Reson Imaging Zu Z. PMID: 42680717 [PubMed - as supplied by publisher]
	Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Zaurito P, Gandaglia G, Montorsi F. PMID: 42680649 [PubMed - as supplied by publisher]
	De-Escalation Therapy in Metastatic Prostate Cancer: A Retrospective Study on Intermittent ADT and ARPI Combination Treatment. Clin Genitourin Cancer Talmor B, Baranseh J, Charas T, Shirron N, Goshenlago T, Crumbaker M, Joshua A, Peer A. PMID: 42680612 [PubMed - as supplied by publisher]
	Real-World Multicentre Evaluation of GALEAS Bladder for Detecting Bladder Cancer in UK NHS Haematuria Clinics. Eur Urol Oncol Silcock L, Hastings RK, Clokie S, Sadler R, Parks M, Smith M, Hewitt V, Douglas-Moore JL, Wignall H, Escabelado H, Piedad J, Kanabar S, Blick C, Mohee A, Pumfrey N, Coull N, Goffe A, Tippett R, Laird A, Shah CP, MacKay M, Owen C, Mufti U, Ward DG, Bryan RT. PMID: 42680595 [PubMed - as supplied by publisher]
	Limited progress in clinical trials for rare urologic cancers: Testicular and penile cancer. Can Urol Assoc J Eigner E, Fazaa N, Nsair A, Atallah M, Bandari J, Amiel GE, Hoffman A, Malshy K. PMID: 42678690 [PubMed - as supplied by publisher]
	Few prostate cancer guidelines are of high methodologic quality and therefore trustworthy. Can Urol Assoc J Tondroanamag F, Gonzalez-Padilla DA, Bakker C, Dahm P. PMID: 42678683 [PubMed - as supplied by publisher]
	Perioperative safety and survival outcomes of robot-assisted partial nephrectomy in elderly patients with localized renal cell carcinoma: an overlap-weighted Asian cohort study. J Robot Surg Wang Z, Li J, Zhuang Y, Baoerbieke Y, Zhang Y, Zeng J. PMID: 42678568 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 181173

Page 1 of 9059



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy